A detailed history of Krane Funds Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Krane Funds Advisors LLC holds 18,650 shares of PFE stock, worth $491,614. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,650
Previous 540 3353.7%
Holding current value
$491,614
Previous $15,000 3493.33%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$27.7 - $31.39 $501,647 - $568,472
18,110 Added 3353.7%
18,650 $539,000
Q3 2024

Oct 16, 2024

SELL
$27.7 - $31.39 $557,296 - $631,535
-20,119 Reduced 97.39%
540 $15,000
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $29,604 - $34,691
-1,172 Reduced 5.37%
20,659 $578,000
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $41,165 - $47,270
1,590 Added 7.86%
21,831 $605,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $30,389 - $39,472
1,163 Added 6.1%
20,241 $582,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $69,378 - $81,096
2,162 Added 12.78%
19,078 $633,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $22,358 - $25,868
619 Added 3.8%
16,916 $620,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $61,645 - $80,253
1,565 Added 10.62%
16,297 $681,000
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $615,061 - $802,894
14,732 New
14,732 $755,000
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $127,585 - $151,276
-2,742 Reduced 33.9%
5,347 $280,000
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $66,932 - $82,937
1,463 Added 22.08%
8,089 $419,000
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $100,531 - $149,021
-2,433 Reduced 26.86%
6,626 $391,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $355,565 - $456,754
9,059 New
9,059 $390,000
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $356,857 - $453,774
-10,662 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $338,518 - $397,159
10,662 New
10,662 $371,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Krane Funds Advisors LLC Portfolio

Follow Krane Funds Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.